Crossmark

Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines

Crossref DOI link: https://doi.org/10.1186/s13244-024-01838-x

Published Online: 2024-10-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Zhe

Zhu, Rong-Hua

Li, Shan-shan

Luo, Hong-Chang

Li, Kai-Yan https://orcid.org/0000-0003-3332-6325
License Information

Text and Data Mining valid from 2024-10-31

Version of Record valid from 2024-10-31
More Information

Article History

Received: 15 May 2024

Accepted: 5 October 2024

First Online: 31 October 2024

Declarations

:

: This retrospective and prospective study was approved by the Tongji Hospital Ethics Committee.

: All authors of the study agreed to the publication of the article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below